Gendoo

MeSH keywords -> Related genes, diseases (OMIM)


Query MeSH keywords list

01 Incidence [NCBI]

Gene


 Gene Link Information
Gain		 01



OMIM


 OMIM Link Information
gain		 01
testicular germ cell tumor 1 [NCBI] 0.00175904
aneurysm, intracranial berry, 1 [NCBI] 0.0016854
CRC [NCBI] 0.00135471
lymphoma, non-hodgkin, familial [NCBI] 0.00111315
KLK3 [NCBI] 0.00105177
temporal arteritis [NCBI] 0.000746897
PPR [NCBI] 0.000729232
twinning, dizygotic [NCBI] 0.000657069
esophagitis, eosinophilic [NCBI] 0.000614996
acne inversa, familial [NCBI] 0.000614996
breast cancer, 11-22 translocation associated [NCBI] 0.000614996
apnea, obstructive sleep [NCBI] 0.000525121
cataract, congenital or juvenile [NCBI] 0.00051683
leprosy, susceptibility to, 1 [NCBI] 0.00051683
mesomelic dysplasia, kantaputra type [NCBI] 0.00051683
cataract, age-related cortical [NCBI] 0.00051683
restless legs syndrome, susceptibility to, 3 [NCBI] 0.00051683
kala-azar, susceptibility to, 1 [NCBI] 0.000453761
CHDM [NCBI] 0.000453761
CJD [NCBI] 0.000451324
diabetes mellitus, insulin-dependent, x-linked, susceptibility to [NCBI] 0.00040736
EOCA [NCBI] 0.000370778
jejunal atresia [NCBI] 0.000370778
vestibulopathy, familial [NCBI] 0.000370778
VRNI [NCBI] 0.000357701
behcet syndrome [NCBI] 0.000346492
neuropathy, hereditary motor and sensory, russe type [NCBI] 0.000340682
APC [NCBI] 0.00033593
klippel-trenaunay-weber syndrome [NCBI] 0.000304998
constricting bands, congenital [NCBI] 0.000293161
OTSC1 [NCBI] 0.000256578
ETL2 [NCBI] 0.000241102
anencephaly [NCBI] 0.000241102
FEB1 [NCBI] 0.000227082
glaucoma-related pigment dispersion syndrome [NCBI] 0.000202557
alopecia areata 1 [NCBI] 0.000202557
panencephalitis, subacute sclerosing [NCBI] 0.000176685
abdominal obesity-metabolic syndrome [NCBI] 0.000172395
IGAN1 [NCBI] 0.000172395
danubian endemic familial nephropathy [NCBI] 0.00016844
VUR1 [NCBI] 0.000155573
G6PD [NCBI] 0.000155005
APOE [NCBI] 0.000146967
NPHS1 [NCBI] 0.000138455
hashimoto thyroiditis [NCBI] 0.000134021
SLE [NCBI] 0.000120189
ARMD1 [NCBI] 0.000114034
MBL2 [NCBI] 0.000108237
BRCA2 [NCBI] 0.000105044
palatopharyngeal incompetence [NCBI] 0.000100458
BRCA1 [NCBI] 9.58529e-05
DWS [NCBI] 9.58056e-05
hemophagocytic lymphohistiocytosis, familial, 1 [NCBI] 8.31134e-05
MDD [NCBI] 8.2587e-05
CPI [NCBI] 7.99732e-05
pulmonary hemosiderosis [NCBI] 7.98281e-05
primordial germ cell tumor susceptibility locus 1 [NCBI] 7.98281e-05
cryptotia, familial [NCBI] 7.98281e-05
brugada syndrome 1 [NCBI] 7.95081e-05
avascular necrosis of femoral head, primary [NCBI] 7.76469e-05
CRP [NCBI] 7.60863e-05
CD [NCBI] 7.49459e-05
AFP [NCBI] 7.22518e-05
PCOS1 [NCBI] 6.86936e-05
NGFB [NCBI] 6.316e-05
GBD1 [NCBI] 6.24233e-05
PEE1 [NCBI] 6.23827e-05
lung cancer [NCBI] 6.18778e-05
EGF [NCBI] 6.01484e-05
SACS [NCBI] 5.51068e-05
urinary tract infections, recurrent, susceptibility to [NCBI] 5.24302e-05
ACCPN [NCBI] 5.19873e-05
kaposi sarcoma [NCBI] 4.9149e-05
NPY [NCBI] 4.51623e-05
LFS1 [NCBI] 4.37e-05
dermatitis herpetiformis, familial [NCBI] 4.23232e-05
keloids [NCBI] 4.23232e-05
cataract, age-related nuclear [NCBI] 4.23232e-05
FEB8 [NCBI] 4.23232e-05
parathyroid carcinoma [NCBI] 4.23232e-05
brugada syndrome 2 [NCBI] 4.23232e-05
diabetic nephropathy, susceptibility to [NCBI] 4.23232e-05
melanoma, uveal [NCBI] 4.11553e-05
PRNP [NCBI] 3.96145e-05
PTH [NCBI] 3.90471e-05
DFSP [NCBI] 3.89244e-05
AVSD [NCBI] 3.86414e-05
MJD [NCBI] 3.80125e-05
pancreatic carcinoma [NCBI] 3.79698e-05
phenylketonuria [NCBI] 3.78119e-05
alopecia, androgenetic [NCBI] 3.62047e-05
VEGF [NCBI] 3.60745e-05
sarcoidosis, early-onset [NCBI] 3.58915e-05
CMT4H [NCBI] 3.58915e-05
pars planitis [NCBI] 3.58915e-05
chondrodysplasia punctata, tibia-metacarpal type [NCBI] 3.58915e-05
lynch syndrome i [NCBI] 3.54268e-05
SLC26A3 [NCBI] 3.54098e-05
NPHS1 [NCBI] 3.4656e-05
ETM1 [NCBI] 3.44959e-05
TH [NCBI] 3.39878e-05
RP [NCBI] 3.36319e-05
NF1 [NCBI] 3.35017e-05
thyroid carcinoma, papillary [NCBI] 3.34939e-05
AD [NCBI] 3.34842e-05
SMA1 [NCBI] 3.31898e-05
aortic aneurysm, abdominal [NCBI] 3.29152e-05
NN [NCBI] 3.12054e-05
ovarian cancer, epithelial [NCBI] 3.12054e-05
young syndrome [NCBI] 3.12054e-05
isoproterenol-mediated vasodilatation [NCBI] 3.12054e-05
VDR [NCBI] 3.09857e-05
acyl-coa dehydrogenase, medium-chain, deficiency of [NCBI] 3.00193e-05
BL [NCBI] 2.86321e-05
DYT1 [NCBI] 2.81739e-05
CCK [NCBI] 2.7732e-05
erythroleukemia, familial [NCBI] 2.75474e-05
DFNB10 [NCBI] 2.75474e-05
DFNB8 [NCBI] 2.75474e-05
gastroschisis [NCBI] 2.75474e-05
sarcosinemia [NCBI] 2.75474e-05
ectopia lentis, isolated [NCBI] 2.75474e-05
thrombophilia [NCBI] 2.75474e-05
DFNA11 [NCBI] 2.75474e-05
IFNA1 [NCBI] 2.57526e-05
BDNF [NCBI] 2.57191e-05
MG [NCBI] 2.57148e-05
thrombocytopenic purpura, autoimmune [NCBI] 2.56206e-05
CRH [NCBI] 2.52683e-05
PWS [NCBI] 2.48734e-05
ESR1 [NCBI] 2.47812e-05
vacterl association with hydrocephalus [NCBI] 2.45687e-05
chromosome 16p13.3 deletion syndrome [NCBI] 2.45687e-05
radioulnar synostosis [NCBI] 2.45687e-05
LSFC [NCBI] 2.45687e-05
CFH [NCBI] 2.45152e-05
ACHE [NCBI] 2.42002e-05
SUCLA2 [NCBI] 2.41962e-05
HFM [NCBI] 2.41018e-05
PRL [NCBI] 2.40114e-05
ADIPOQ [NCBI] 2.30368e-05
homocysteinemia [NCBI] 2.29819e-05
FFI [NCBI] 2.22851e-05
CFTR [NCBI] 2.21974e-05
CENPI [NCBI] 2.21898e-05
PRKCH [NCBI] 2.21898e-05
IFNA17 [NCBI] 2.21898e-05
GPD1L [NCBI] 2.21898e-05
proteinuria, low molecular weight, with hypercalciuria and nephrocalcinosis [NCBI] 2.20729e-05
citrullinemia, type ii, neonatal-onset [NCBI] 2.20729e-05
ehlers-danlos syndrome, type iii [NCBI] 2.20729e-05
vacterl association with hydrocephalus, x-linked [NCBI] 2.20729e-05
rheumatoid arthritis, systemic juvenile [NCBI] 2.20729e-05
CMT4B1 [NCBI] 2.20729e-05
ODG2 [NCBI] 2.20729e-05
DFNB3 [NCBI] 2.20729e-05
TCF7L2 [NCBI] 2.2062e-05
PD [NCBI] 2.17573e-05
DGS [NCBI] 2.16268e-05
MLL [NCBI] 2.16065e-05
CHH [NCBI] 2.10397e-05
FH [NCBI] 2.09586e-05
SH3TC2 [NCBI] 2.07017e-05
ALD [NCBI] 2.00555e-05
CMT4B2 [NCBI] 1.99381e-05
ACADM [NCBI] 1.97581e-05
ASPH [NCBI] 1.9519e-05
ATF3 [NCBI] 1.94069e-05
VHL [NCBI] 1.89752e-05
WBS [NCBI] 1.87928e-05
XPNPEP2 [NCBI] 1.85379e-05
IL23R [NCBI] 1.85379e-05
MPO [NCBI] 1.81793e-05
CTLN2 [NCBI] 1.80835e-05
NYS1 [NCBI] 1.80835e-05
severe cutaneous adverse reaction, susceptibility to [NCBI] 1.80835e-05
CMT4C [NCBI] 1.80835e-05
CMT4D [NCBI] 1.80835e-05
LDLR [NCBI] 1.78618e-05
KCNJ8 [NCBI] 1.77003e-05
SLC25A13 [NCBI] 1.77003e-05
CCL4L1 [NCBI] 1.77003e-05
MAPKAPK2 [NCBI] 1.69698e-05
TPO [NCBI] 1.6694e-05
corpus callosum, agenesis of [NCBI] 1.64528e-05
hydrolethalus syndrome 1 [NCBI] 1.64528e-05
kawasaki disease [NCBI] 1.64528e-05
ATS [NCBI] 1.64528e-05
scheie syndrome [NCBI] 1.64528e-05
cirrhosis, familial [NCBI] 1.64528e-05
MALT1 [NCBI] 1.63226e-05
factor v deficiency [NCBI] 1.60758e-05
CCL4 [NCBI] 1.57419e-05
PAX7 [NCBI] 1.57419e-05
VHL [NCBI] 1.55764e-05
DRPLA [NCBI] 1.53217e-05
MSH3 [NCBI] 1.52154e-05
mitochondrial dna depletion syndrome, myopathic form [NCBI] 1.50051e-05
CDA [NCBI] 1.50051e-05
sarcoidosis [NCBI] 1.50051e-05
CMT4A [NCBI] 1.50051e-05
ALUNC [NCBI] 1.50051e-05
HEXA [NCBI] 1.49872e-05
LTA4H [NCBI] 1.47343e-05
NDRG1 [NCBI] 1.47343e-05
TPM1 [NCBI] 1.42913e-05
IKBKAP [NCBI] 1.42913e-05
GARS [NCBI] 1.42913e-05
ATXN2 [NCBI] 1.42913e-05
MFS [NCBI] 1.40685e-05
3-@hydroxy-3-methylglutaryl-coa lyase deficiency [NCBI] 1.38812e-05
PCSK9 [NCBI] 1.38812e-05
CD14 [NCBI] 1.38812e-05
PRX [NCBI] 1.38812e-05
HIC1 [NCBI] 1.38812e-05
MTMR2 [NCBI] 1.38812e-05
KRT20 [NCBI] 1.37103e-05
adrenal hyperplasia, congenital, due to steroid 11-beta-hydroxylase deficiency [NCBI] 1.37097e-05
CDGG1 [NCBI] 1.37097e-05
GDAP1 [NCBI] 1.34995e-05
ECE1 [NCBI] 1.34995e-05
CPB2 [NCBI] 1.33219e-05
ALOX5 [NCBI] 1.31426e-05
GABRG2 [NCBI] 1.28076e-05
IL17A [NCBI] 1.28076e-05
PPS [NCBI] 1.25431e-05
HMN5 [NCBI] 1.25431e-05
amyotrophic lateral sclerosis-parkinsonism/dementia complex 1 [NCBI] 1.25431e-05
niemann-pick disease, type b [NCBI] 1.25431e-05
BBS [NCBI] 1.25423e-05
PTS [NCBI] 1.24921e-05
APOB [NCBI] 1.22534e-05
XRCC9 [NCBI] 1.2194e-05
PCCB [NCBI] 1.2194e-05
KCNJ2 [NCBI] 1.2194e-05
KRIT1 [NCBI] 1.2194e-05
ATM [NCBI] 1.20838e-05
HP [NCBI] 1.20491e-05
EGFR [NCBI] 1.19704e-05
aortic valve disease [NCBI] 1.19122e-05
MME [NCBI] 1.19116e-05
phenylketonuria ii [NCBI] 1.19116e-05
SHBG [NCBI] 1.17013e-05
CLCN5 [NCBI] 1.16433e-05
esophageal cancer [NCBI] 1.1487e-05
propionic acidemia [NCBI] 1.1487e-05
vitamin d-dependent rickets, type i [NCBI] 1.1487e-05
CTHM [NCBI] 1.1487e-05
SCZD4 [NCBI] 1.1487e-05
PALS [NCBI] 1.1487e-05
NR3C2 [NCBI] 1.11444e-05
HPS [NCBI] 1.09057e-05
EGR2 [NCBI] 1.06888e-05
SRD5A2 [NCBI] 1.06888e-05
HSCR1 [NCBI] 1.06842e-05
ASPS [NCBI] 1.05265e-05
severe combined immunodeficiency with sensitivity to ionizing radiation [NCBI] 1.05265e-05
GJA5 [NCBI] 1.02699e-05
PON1 [NCBI] 1.01793e-05
sickle cell anemia [NCBI] 9.92915e-06
SMPD1 [NCBI] 9.88254e-06
AVP [NCBI] 9.86364e-06
alkaptonuria [NCBI] 9.64964e-06
CIPA [NCBI] 9.64964e-06
diarrhea 1, secretory chloride, congenital [NCBI] 9.64964e-06
ICP [NCBI] 9.64964e-06
neuropathy, congenital hypomyelinating [NCBI] 9.64964e-06
EDN3 [NCBI] 9.5226e-06
ATXN1 [NCBI] 9.5226e-06
COL4A5 [NCBI] 9.5226e-06
MSH6 [NCBI] 9.5226e-06
CD40LG [NCBI] 9.5226e-06
HHF2 [NCBI] 9.47886e-06
OCP [NCBI] 9.47886e-06
CCM [NCBI] 9.47886e-06
IL18 [NCBI] 9.35184e-06
PTPN11 [NCBI] 9.35184e-06
CETP [NCBI] 9.35184e-06
CAPN3 [NCBI] 9.35184e-06
HLA-B [NCBI] 9.18671e-06
GIST [NCBI] 8.91843e-06
SCN1 [NCBI] 8.84658e-06
PIGA [NCBI] 8.72196e-06
coproporphyria [NCBI] 8.57633e-06
XPA [NCBI] 8.43494e-06
glycogen storage disease i [NCBI] 8.43494e-06
FOXO1A [NCBI] 8.43494e-06
TFPI [NCBI] 8.31884e-06
RS1 [NCBI] 8.29756e-06
PKLR [NCBI] 8.16399e-06
GEFS+ [NCBI] 8.10912e-06
ATP7B [NCBI] 8.03405e-06
STK11 [NCBI] 8.03405e-06
CD [NCBI] 7.82393e-06
ABCA4 [NCBI] 7.78438e-06
AS [NCBI] 7.67804e-06
HEXB [NCBI] 7.66434e-06
LPA [NCBI] 7.66434e-06
AMACR [NCBI] 7.66434e-06
ENG [NCBI] 7.54731e-06
TNFSF6 [NCBI] 7.52835e-06
RUNX1 [NCBI] 7.43315e-06
stroke, ischemic [NCBI] 7.43032e-06
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-positive [NCBI] 7.43032e-06
ORW2 [NCBI] 7.43032e-06
SCA10 [NCBI] 7.43032e-06
autonomic control, congenital failure of [NCBI] 7.43032e-06
HD [NCBI] 7.30691e-06
PGR [NCBI] 7.07886e-06
EV [NCBI] 6.92755e-06
MS [NCBI] 6.92755e-06
PCNA [NCBI] 6.87828e-06
CDPX1 [NCBI] 6.80432e-06
histidinemia [NCBI] 6.80432e-06
gm1-gangliosidosis, type i [NCBI] 6.80432e-06
isoniazid inactivation [NCBI] 6.8022e-06
DBA [NCBI] 6.75594e-06
CAT [NCBI] 6.63039e-06
FA [NCBI] 6.54873e-06
BWS [NCBI] 6.51679e-06
FMF [NCBI] 6.45569e-06
GTS [NCBI] 6.45368e-06
A2M [NCBI] 6.33689e-06
C3 [NCBI] 6.33689e-06
F2 [NCBI] 6.24949e-06
REN [NCBI] 6.24949e-06
PPH1 [NCBI] 6.22609e-06
IP [NCBI] 6.15976e-06
PTHLH [NCBI] 6.01696e-06
IGF1 [NCBI] 5.99751e-06
PKD2 [NCBI] 5.91673e-06
KRAS [NCBI] 5.91673e-06
MTND4 [NCBI] 5.91673e-06
RTT [NCBI] 5.81611e-06
CHNG2 [NCBI] 5.69127e-06
niemann-pick disease, type a [NCBI] 5.69127e-06
hodgkin lymphoma [NCBI] 5.69127e-06
PF4 [NCBI] 5.68379e-06
UGT1A1 [NCBI] 5.68335e-06
BIRC1 [NCBI] 5.60839e-06
CMH [NCBI] 5.60242e-06
AKR1B1 [NCBI] 5.4563e-06
NR5A1 [NCBI] 5.39143e-06
CF [NCBI] 5.3637e-06
ACPP [NCBI] 5.26625e-06
HGF [NCBI] 5.231e-06
HOKPP [NCBI] 5.19609e-06
andersen cardiodysrhythmic periodic paralysis [NCBI] 5.19609e-06
IL10 [NCBI] 5.18556e-06
MC4R [NCBI] 5.11925e-06
AT [NCBI] 5.09578e-06
VCP [NCBI] 5.05403e-06
FSHR [NCBI] 5.05403e-06
CHAT [NCBI] 5.04622e-06
LRRK2 [NCBI] 4.98989e-06
MLH1 [NCBI] 4.86471e-06
RYR1 [NCBI] 4.80362e-06
NEM3 [NCBI] 4.73725e-06
FDH [NCBI] 4.73725e-06
PDB [NCBI] 4.73725e-06
MTTL1 [NCBI] 4.68431e-06
velocardiofacial syndrome [NCBI] 4.67262e-06
TG [NCBI] 4.64411e-06
TS [NCBI] 4.61341e-06
MTR [NCBI] 4.56868e-06
TP53 [NCBI] 4.56811e-06
MBP [NCBI] 4.44329e-06
ASS [NCBI] 4.34774e-06
osteoarthritis [NCBI] 4.31183e-06
ALB [NCBI] 4.17074e-06
krabbe disease [NCBI] 4.0359e-06
SRS [NCBI] 3.9748e-06
IDDM [NCBI] 3.9748e-06
PJS [NCBI] 3.95837e-06
TYMS [NCBI] 3.92436e-06
MEN1 [NCBI] 3.89554e-06
homocystinuria [NCBI] 3.84875e-06
WHS [NCBI] 3.71139e-06
hla-d histocompatibility type [NCBI] 3.63501e-06
ADA [NCBI] 3.63439e-06
GH1 [NCBI] 3.58101e-06
AR [NCBI] 3.57032e-06
PPSH [NCBI] 3.55125e-06
musical perfect pitch [NCBI] 3.55125e-06
usher syndrome, type i [NCBI] 3.55125e-06
SRY [NCBI] 3.49642e-06
GDNF [NCBI] 3.37748e-06
MC1R [NCBI] 3.33369e-06
INS [NCBI] 3.2961e-06
PG [NCBI] 3.2943e-06
CVID [NCBI] 3.24174e-06
NRG1 [NCBI] 3.21699e-06
testicular tumors [NCBI] 3.21177e-06
FBN1 [NCBI] 3.1046e-06
APS1 [NCBI] 3.09095e-06
LPL [NCBI] 3.04508e-06
ABCC8 [NCBI] 2.96106e-06
SLOS [NCBI] 2.8688e-06
dystrophia myotonica 1 [NCBI] 2.80313e-06
PKD1 [NCBI] 2.79112e-06
TPMT [NCBI] 2.79112e-06
breast cancer [NCBI] 2.70682e-06
CCND1 [NCBI] 2.66224e-06
exostoses, multiple, type i [NCBI] 2.60524e-06
CDKN2A [NCBI] 2.60002e-06
von willebrand disease [NCBI] 2.60002e-06
HBA2 [NCBI] 2.50934e-06
RA [NCBI] 2.48588e-06
IS1 [NCBI] 2.42326e-06
human immunodeficiency virus type 1, susceptibility to [NCBI] 2.33506e-06
gastric cancer [NCBI] 2.33506e-06
GNRH1 [NCBI] 2.30481e-06
KDR [NCBI] 2.28207e-06
MODY [NCBI] 2.27502e-06
MAFD6 [NCBI] 2.19155e-06
LAM [NCBI] 2.1808e-06
UCP1 [NCBI] 2.12442e-06
CVS [NCBI] 2.08509e-06
mitochondrial complex iv deficiency [NCBI] 2.08509e-06
LGMD2A [NCBI] 2.08509e-06
BGLAP [NCBI] 2.0494e-06
ABCB1 [NCBI] 1.97677e-06
TF [NCBI] 1.87634e-06
EVA [NCBI] 1.85411e-06
LEP [NCBI] 1.79411e-06
TERT [NCBI] 1.77234e-06
PXE [NCBI] 1.65085e-06
RNASE3 [NCBI] 1.6502e-06
CADASIL [NCBI] 1.641e-06
PCTT [NCBI] 1.641e-06
TBS [NCBI] 1.641e-06
SJS1 [NCBI] 1.641e-06
sandhoff disease [NCBI] 1.641e-06
CNTF [NCBI] 1.60608e-06
hemophilia a [NCBI] 1.52824e-06
apc gene [NCBI] 1.50924e-06
wilson disease [NCBI] 1.49418e-06
NS1 [NCBI] 1.49248e-06
TTR [NCBI] 1.48392e-06
CLN3 [NCBI] 1.44473e-06
kartagener syndrome [NCBI] 1.44473e-06
malaria, susceptibility to [NCBI] 1.44473e-06
TNF [NCBI] 1.42702e-06
APP [NCBI] 1.41713e-06
leber optic atrophy [NCBI] 1.29321e-06
ACE [NCBI] 1.27663e-06
HFE [NCBI] 1.2304e-06
COMT [NCBI] 1.1146e-06
CTNS [NCBI] 1.09908e-06
mucolipidosis ii [NCBI] 1.09908e-06
aHUS [NCBI] 1.09908e-06
MAS [NCBI] 1.04389e-06
SCA2 [NCBI] 9.64527e-07
SDS [NCBI] 9.64527e-07
HHF1 [NCBI] 9.48038e-07
F3 [NCBI] 8.5629e-07
POAG [NCBI] 8.10525e-07
JAK2 [NCBI] 7.81345e-07
TSD [NCBI] 7.59717e-07
TLR2 [NCBI] 7.1491e-07
TLR4 [NCBI] 6.87603e-07
RSTS [NCBI] 6.85865e-07
pyruvate kinase deficiency of red cells [NCBI] 6.85865e-07
PLG [NCBI] 6.72894e-07
amyloidosis vi [NCBI] 6.41503e-07
ACP5 [NCBI] 6.23845e-07
ALS1 [NCBI] 6.12284e-07
fabry disease [NCBI] 6.08111e-07
RB1 [NCBI] 6.03535e-07
HSAN3 [NCBI] 5.7343e-07
SOD2 [NCBI] 5.46573e-07
hypogonadotropic hypogonadism [NCBI] 5.34919e-07
menkes disease [NCBI] 5.34919e-07
LI1 [NCBI] 4.72637e-07
RTS [NCBI] 4.72637e-07
SERPINA6 [NCBI] 4.24628e-07
FGFR3 [NCBI] 4.02357e-07
BCNS [NCBI] 3.89119e-07
PCD [NCBI] 3.42509e-07
ND [NCBI] 3.30608e-07
SOD1 [NCBI] 3.14488e-07
SCIDX1 [NCBI] 3.03854e-07
DYT1 [NCBI] 3.03854e-07
SCA1 [NCBI] 2.99143e-07
PPARA [NCBI] 2.56304e-07
porphyria variegata [NCBI] 2.19032e-07
CEACAM5 [NCBI] 1.85971e-07
neuroblastoma [NCBI] 1.75606e-07
ADHD [NCBI] 1.34376e-07
OPMD [NCBI] 1.34376e-07
prostate cancer [NCBI] 1.28678e-07
hypertrophic neuropathy of dejerine-sottas [NCBI] 1.256e-07
glioma of brain, familial [NCBI] 1.256e-07
NF2 [NCBI] 8.44811e-08
SCZD [NCBI] 7.74166e-08
AMC [NCBI] 5.18877e-08
FRAP1 [NCBI] 3.15236e-08
WS1 [NCBI] 2.74786e-08
hypercholesterolemia, autosomal dominant [NCBI] 2.18821e-08
STAT3 [NCBI] 1.3502e-08
FRDA [NCBI] 1.1036e-08
bullous erythroderma ichthyosiformis congenita of brocq [NCBI] 1.0933e-08
EPO [NCBI] 7.53408e-09
FTD [NCBI] 5.29204e-09
TNFRSF11B [NCBI] 1.06472e-09
MAG [NCBI] 8.97476e-10
hurler syndrome [NCBI] 2.40529e-10
polycystic kidneys [NCBI] 1.1096e-10



Database Center for Life Science